Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV6Q4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,923
Award facts
- Contract value 100% obligated
- $1,922.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,922.98 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 mL auto-injector syringes. This firm fixed-price delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-set-aside, competitively awarded procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationship with DLA to fulfill pharmaceutical supply needs for federal military and healthcare systems.
This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle that extends through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Xyosted, a testosterone replacement therapy auto-injector, represents the type of specialized pharmaceutical product delivered through this flexible contract mechanism to serve the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV6Q4?
SPE2DR26FV6Q4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FV6Q4 worth?
The government has obligated $1,923 on SPE2DR26FV6Q4.
Is contract SPE2DR26FV6Q4 an order under another contract?
Yes. SPE2DR26FV6Q4 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6Q4 competed?
The extent of competition for SPE2DR26FV6Q4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award